Stroke Diagnostic and Therapeutic Market Revenue 2024 to 2034

Stroke Diagnostic and Therapeutic Market Revenue 2024 to 2034

The stroke diagnostic and therapeutic market will expand from USD 38.98 Bn in 2024 to USD 83.84 Bn by 2034, at a 7.96% CAGR, fueled by rising stroke incidence, demand for early detection, and advances in clot removal therapies.

Report ID: 10588 | Format: Databook | Published: August 2025 | Delivery: Immediate
Download Sample     Customisation Request  

Revenue,

USD 38.98 Bn

Forecast Year,

USD 83.84 Bn

CAGR, 2025 -

7.96%

Report Coverage

Worldwide

Reviewed By

Aditi Shivarkar

Reviewed By

Aman Singh

Stroke Diagnostic and Therapeutic Market Size Analysis

Stroke Diagnostic and Therapeutic Market Size By Type 2024 to 2034 (USD )

Type 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
Diagnostics21.0522.7524.5926.5728.7231.0433.5436.2539.1742.3445.75
Therapeutics17.9319.3320.8522.4824.2426.1328.1830.3832.7635.3338.09

Stroke Diagnostic and Therapeutic Market Size Diagnostics Breakdown 2024 to 2034 (USD )

Diagnostics Breakdown 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
MRI10.9111.8312.8313.9115.0716.3417.7119.2020.8122.5524.44
CT Scan9.3610.0210.7411.5012.3213.1914.1315.1316.2117.3618.59
ECG6.246.747.297.888.529.219.9510.7611.6312.5713.59
Carotid Ultrasound4.685.015.375.766.176.617.087.598.138.719.33
Cerebral Angiography3.904.234.605.005.435.896.406.957.548.198.89
Others3.904.244.615.015.455.936.457.017.628.289.00

Stroke Diagnostic and Therapeutic Market Size Therapeutics Breakdown 2024 to 2034 (USD )

Therapeutics Breakdown 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
tPA9.3610.0510.8011.6012.4613.3914.3815.4516.5917.8219.15
Antiplatelet10.9111.7112.5613.4714.4515.5116.6317.8419.1420.5222.01
Antihypertensive8.589.3110.1110.9711.9112.9314.0415.2416.5417.9519.48
Anticoagulant10.1311.0111.9713.0014.1215.3416.6718.1119.6721.3623.20

Stroke Diagnostic and Therapeutic Market Size By Application 2024 to 2034 (USD )

Application 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
Ischemic Stroke30.4032.8435.4838.3241.3944.7148.3052.1756.3560.8765.75
Hemorrhagic Stroke8.589.249.9610.7311.5612.4613.4214.4615.5816.7918.09

Stroke Diagnostic and Therapeutic Market Size By Region 2024 to 2034 (USD )

Region 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
North America14.0315.2016.4517.8219.2920.8922.6224.4926.5128.7131.08
Europe10.9111.7312.6013.5414.5515.6316.8018.0519.3920.8322.38
Asia Pacific11.3012.1813.1114.1215.2116.3817.6519.0020.4722.0523.74
Latin America1.561.701.842.012.182.372.582.803.053.313.60
Middle East & Africa1.171.291.421.561.721.892.082.292.522.763.03

Stroke Diagnostic and Therapeutic Market

Stroke Diagnostic and Therapeutic Market

Our Client